Skip to main content
logo
Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
3.230
-0.090 (-2.71%)
At close: Aug 28, 2026, 4:00 PM EDT
3.230
0.00 (-0.01%)
After-hours: Aug 28, 2026, 7:30 PM EDT

Pyxis Oncology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
26972938047353
Market Cap Growth
219.41%-22.81%16.32%70.77%-86.78%-
Enterprise Value
25414-32-32-136414
Last Close Price
3.231.151.561.801.3410.97

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
24.415.175.75---
PB Ratio
17.911.340.770.630.291.35
P/TBV Ratio
23.551.340.790.790.291.35

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
23.031.04----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
1.560.350.170.170.120.00
Net Debt / Equity Ratio
-1.33-0.90-0.88-0.78-1.00-1.05
Net Debt / EBITDA Ratio
0.180.621.711.251.313.98
Net Debt / FCF Ratio
0.220.761.841.261.687.66
Asset Turnover
0.120.110.10---
Quick Ratio
1.203.207.184.635.6914.69
Current Ratio
1.343.417.494.845.9014.90
Return on Equity (ROE)
-179.10%-91.44%-62.76%-51.51%-57.19%-56.78%
Return on Assets (ROA)
-62.95%-41.14%-24.77%-26.10%-31.41%-30.03%
Return on Capital Employed (ROCE)
-326.80%-116.30%-47.00%-54.30%-68.70%-26.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-32.93%-111.20%-83.36%-92.53%-258.50%-21.50%
FCF Yield
-25.21%-88.70%-62.42%-97.10%-205.00%-10.15%
Buyback Yield / Dilution
-3.27%-6.33%-46.46%-20.80%-288.93%-724.14%
SEC Filings: 10-K · 10-Q